Literature DB >> 6780413

Allergic proctitis, a clinical and immunopathological entity.

P C Rosekrans, C J Meijer, A M van der Wal, J Lindeman.   

Abstract

Patients with isolated ulcerative proctitis form a heterogeneous group. Some may develop ulcerative colitis, others have a limited, benign disease. Twelve patients with isolated proctitis with a mean course of seven years were studied. All patients had a typical clinical picture consisting of a mild and intermittent course of the disease with the presenting symptom of rectal blood loss. At endoscopic examination the inflammatory process was limited to the rectal and distal sigmoid colonic mucosa with a clear upper border beyond which the mucosa of the sigmoid colon was normal. Histologically the mucosal biopsy specimens of the affected rectum resembled those of ulcerative colitis. However, in contrast with proctitis on the base of ulcerative colitis or Crohn's disease, immunoperoxidase staining revealed a markedly increased number of IgE containing cells in the lamina propria of rectal mucosa biopsies. As an IgE-mediated immune mechanism was considered to play a role in this type of proctitis, eight of the 12 patients were treated with oral administration of disodium cromoglycate (DSCG). All patients were improved by the drug. The remaining four patients with mild proctitis did not require treatment. We concluded that, in patients with isolated proctitis on clinical and immunopathological criteria, a group can be separated which responds to DSCG, a condition for which we suggest the name 'allergic proctitis'.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6780413      PMCID: PMC1419398          DOI: 10.1136/gut.21.12.1017

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Intestinal immunoglobulins in ulcerative colitis.

Authors:  J Söltoft; V Binder; E Gudmand-Höyer
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

2.  The distribution of immunoglobulin-containing cells along the human gastrointestinal tract.

Authors:  P A Crabbé; J F Heremans
Journal:  Gastroenterology       Date:  1966-09       Impact factor: 22.682

Review 3.  Disodium cromoglycate. Mode of action and its possible relevance to the clinical use of the drug.

Authors:  J S Cox
Journal:  Br J Dis Chest       Date:  1971-10

4.  Distribution of immunoglobulins in human rectal mucosa. II. Ulcerative colitis and abnormal mucosal control subjects.

Authors:  E A Gelzayd; S C Kraft; F W Fitch; J B Kirsner
Journal:  Gastroenterology       Date:  1968-03       Impact factor: 22.682

Review 5.  Current concepts: ulcerative proctitis.

Authors:  J H Folley
Journal:  N Engl J Med       Date:  1970-06-11       Impact factor: 91.245

6.  Clinical crse of ulcerative proctosigmoiditis.

Authors:  F W Nugent; M C Veidenheimer; S Zuberi; M M Garabedian; N K Parikh
Journal:  Am J Dig Dis       Date:  1970-04

7.  Circulating and tissue eosinophils in ulcerative colitis.

Authors:  R Wright; S C Truelove
Journal:  Am J Dig Dis       Date:  1966-11

8.  Disodium cromoglycate in the treatment of chronic proctitis.

Authors:  R V Heatley; B J Calcraft; J Rhodes; E Owen; B K Evans
Journal:  Gut       Date:  1975-07       Impact factor: 23.059

9.  Reaginic hypersensitivity in ulcerative colitis.

Authors:  D P Jewell; S C Truelove
Journal:  Gut       Date:  1972-11       Impact factor: 23.059

10.  Circulating antibodies to cow's milk proteins in ulcerative colitis.

Authors:  D P Jewell; S C Truelove
Journal:  Gut       Date:  1972-10       Impact factor: 23.059

View more
  9 in total

1.  Ulcerative proctitis in central Sweden 1965-1983. A population-based epidemiological study.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

Review 2.  The immunologic basis of inflammatory bowel disease.

Authors:  W Strober; S P James
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

3.  Lymphoid follicular proctitis. A condition different from ulcerative proctitis?

Authors:  J F Fléjou; F Potet; W V Bogomoletz; C Rigaud; A Fenzy; Y Le Quintrec; D Goldfain; N Brousse
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

4.  Evaluation of mucosal eosinophils in the pediatric colon.

Authors:  Licia Pensabene; Marie-Anne Brundler; Juliane M Bank; Carlo Di Lorenzo
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

5.  Increased numbers of IgE containing cells in gastric and duodenal biopsies. An expression of food allergy secondary to chronic inflammation?

Authors:  J P van Spreeuwel; J Lindeman; J van Maanen; C J Meyer
Journal:  J Clin Pathol       Date:  1984-06       Impact factor: 3.411

6.  Rectal mucosal plasma cells in inflammatory bowel disease.

Authors:  B B Scott; A Goodall; P Stephenson; D Jenkins
Journal:  Gut       Date:  1983-06       Impact factor: 23.059

7.  Human intestinal mucosal mast cells: expanded population in untreated coeliac disease.

Authors:  S Strobel; A Busuttil; A Ferguson
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

8.  Spirochaetosis of the human rectum associated with an intraepithelial mast cell and IgE plasma cell response.

Authors:  J O Gebbers; D J Ferguson; C Mason; P Kelly; D P Jewell
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

9.  Combination therapy using fexofenadine, disodium cromoglycate, and a hypoallergenic amino acid-based formula induced remission in a patient with steroid-dependent, chronically active ulcerative colitis.

Authors:  M Raithel; S Winterkamp; M Weidenhiller; S Müller; E G Hahn
Journal:  Int J Colorectal Dis       Date:  2006-03-31       Impact factor: 2.796

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.